202 related articles for article (PubMed ID: 9516414)
1. Amino-terminal truncation of chemokines by CD26/dipeptidyl-peptidase IV. Conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1-infection.
Proost P; De Meester I; Schols D; Struyf S; Lambeir AM; Wuyts A; Opdenakker G; De Clercq E; Scharpé S; Van Damme J
J Biol Chem; 1998 Mar; 273(13):7222-7. PubMed ID: 9516414
[TBL] [Abstract][Full Text] [Related]
2. CD26-processed RANTES(3-68), but not intact RANTES, has potent anti-HIV-1 activity.
Schols D; Proost P; Struyf S; Wuyts A; De Meester I; Scharpé S; Van Damme J; De Clercq E
Antiviral Res; 1998 Oct; 39(3):175-87. PubMed ID: 9833958
[TBL] [Abstract][Full Text] [Related]
3. Cleavage by CD26/dipeptidyl peptidase IV converts the chemokine LD78beta into a most efficient monocyte attractant and CCR1 agonist.
Proost P; Menten P; Struyf S; Schutyser E; De Meester I; Van Damme J
Blood; 2000 Sep; 96(5):1674-80. PubMed ID: 10961862
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage.
Oravecz T; Pall M; Roderiquez G; Gorrell MD; Ditto M; Nguyen NY; Boykins R; Unsworth E; Norcross MA
J Exp Med; 1997 Dec; 186(11):1865-72. PubMed ID: 9382885
[TBL] [Abstract][Full Text] [Related]
5. Truncation of macrophage-derived chemokine by CD26/ dipeptidyl-peptidase IV beyond its predicted cleavage site affects chemotactic activity and CC chemokine receptor 4 interaction.
Proost P; Struyf S; Schols D; Opdenakker G; Sozzani S; Allavena P; Mantovani A; Augustyns K; Bal G; Haemers A; Lambeir AM; Scharpé S; Van Damme J; De Meester I
J Biol Chem; 1999 Feb; 274(7):3988-93. PubMed ID: 9933589
[TBL] [Abstract][Full Text] [Related]
6. Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties.
Proost P; Schutyser E; Menten P; Struyf S; Wuyts A; Opdenakker G; Detheux M; Parmentier M; Durinx C; Lambeir AM; Neyts J; Liekens S; Maudgal PC; Billiau A; Van Damme J
Blood; 2001 Dec; 98(13):3554-61. PubMed ID: 11739156
[TBL] [Abstract][Full Text] [Related]
7. Processing by CD26/dipeptidyl-peptidase IV reduces the chemotactic and anti-HIV-1 activity of stromal-cell-derived factor-1alpha.
Proost P; Struyf S; Schols D; Durinx C; Wuyts A; Lenaerts JP; De Clercq E; De Meester I; Van Damme J
FEBS Lett; 1998 Jul; 432(1-2):73-6. PubMed ID: 9710254
[TBL] [Abstract][Full Text] [Related]
8. CD26/dipeptidyl peptidase IV differentially regulates the chemotaxis of T cells and monocytes toward RANTES: possible mechanism for the switch from innate to acquired immune response.
Iwata S; Yamaguchi N; Munakata Y; Ikushima H; Lee JF; Hosono O; Schlossman SF; Morimoto C
Int Immunol; 1999 Mar; 11(3):417-26. PubMed ID: 10221653
[TBL] [Abstract][Full Text] [Related]
9. Functional comparison of two human monocyte chemotactic protein-2 isoforms, role of the amino-terminal pyroglutamic acid and processing by CD26/dipeptidyl peptidase IV.
Van Coillie E; Proost P; Van Aelst I; Struyf S; Polfliet M; De Meester I; Harvey DJ; Van Damme J; Opdenakker G
Biochemistry; 1998 Sep; 37(36):12672-80. PubMed ID: 9730840
[TBL] [Abstract][Full Text] [Related]
10. Dipeptidyl peptidase IV (CD26) on T cells cleaves the CXC chemokine CXCL11 (I-TAC) and abolishes the stimulating but not the desensitizing potential of the chemokine.
Ludwig A; Schiemann F; Mentlein R; Lindner B; Brandt E
J Leukoc Biol; 2002 Jul; 72(1):183-91. PubMed ID: 12101279
[TBL] [Abstract][Full Text] [Related]
11. Good or evil: CD26 and HIV infection.
Ohtsuki T; Tsuda H; Morimoto C
J Dermatol Sci; 2000 Apr; 22(3):152-60. PubMed ID: 10698152
[TBL] [Abstract][Full Text] [Related]
12. CD26/dipeptidyl-peptidase IV down-regulates the eosinophil chemotactic potency, but not the anti-HIV activity of human eotaxin by affecting its interaction with CC chemokine receptor 3.
Struyf S; Proost P; Schols D; De Clercq E; Opdenakker G; Lenaerts JP; Detheux M; Parmentier M; De Meester I; Scharpé S; Van Damme J
J Immunol; 1999 Apr; 162(8):4903-9. PubMed ID: 10202035
[TBL] [Abstract][Full Text] [Related]
13. CD26/dipeptidylpeptidase IV-chemokine interactions: double-edged regulation of inflammation and tumor biology.
Mortier A; Gouwy M; Van Damme J; Proost P; Struyf S
J Leukoc Biol; 2016 Jun; 99(6):955-69. PubMed ID: 26744452
[TBL] [Abstract][Full Text] [Related]
14. Multiple pathways of amino terminal processing produce two truncated variants of RANTES/CCL5.
Lim JK; Burns JM; Lu W; DeVico AL
J Leukoc Biol; 2005 Aug; 78(2):442-52. PubMed ID: 15923218
[TBL] [Abstract][Full Text] [Related]
15. Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1alpha (SDF-1alpha) and SDF-1beta are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage.
Shioda T; Kato H; Ohnishi Y; Tashiro K; Ikegawa M; Nakayama EE; Hu H; Kato A; Sakai Y; Liu H; Honjo T; Nomoto A; Iwamoto A; Morimoto C; Nagai Y
Proc Natl Acad Sci U S A; 1998 May; 95(11):6331-6. PubMed ID: 9600965
[TBL] [Abstract][Full Text] [Related]
16. Kinetic investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family.
Lambeir AM; Proost P; Durinx C; Bal G; Senten K; Augustyns K; Scharpé S; Van Damme J; De Meester I
J Biol Chem; 2001 Aug; 276(32):29839-45. PubMed ID: 11390394
[TBL] [Abstract][Full Text] [Related]
17. Isolation of the CXC chemokines ENA-78, GRO alpha and GRO gamma from tumor cells and leukocytes reveals NH2-terminal heterogeneity. Functional comparison of different natural isoforms.
Wuyts A; Govaerts C; Struyf S; Lenaerts JP; Put W; Conings R; Proost P; Van Damme J
Eur J Biochem; 1999 Mar; 260(2):421-9. PubMed ID: 10095777
[TBL] [Abstract][Full Text] [Related]
18. NH2- and COOH-terminal truncations of murine granulocyte chemotactic protein-2 augment the in vitro and in vivo neutrophil chemotactic potency.
Wuyts A; D'Haese A; Cremers V; Menten P; Lenaerts JP; De Loof A; Heremans H; Proost P; Van Damme J
J Immunol; 1999 Dec; 163(11):6155-63. PubMed ID: 10570306
[TBL] [Abstract][Full Text] [Related]
19. Negative regulation of the anti-human immunodeficiency virus and chemotactic activity of human stromal cell-derived factor 1alpha by CD26/dipeptidyl peptidase IV.
Ohtsuki T; Hosono O; Kobayashi H; Munakata Y; Souta A; Shioda T; Morimoto C
FEBS Lett; 1998 Jul; 431(2):236-40. PubMed ID: 9708910
[TBL] [Abstract][Full Text] [Related]
20. Natural truncation of RANTES abolishes signaling through the CC chemokine receptors CCR1 and CCR3, impairs its chemotactic potency and generates a CC chemokine inhibitor.
Struyf S; De Meester I; Scharpé S; Lenaerts JP; Menten P; Wang JM; Proost P; Van Damme J
Eur J Immunol; 1998 Apr; 28(4):1262-71. PubMed ID: 9565366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
